Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANDA-SCAP: Corticosteroids in sCAP
NCT07152587Phase 3Not yet recruiting
- Sponsor
- Qingyuan Zhan
- Start
- Sep 2025
- Primary completion
- Dec 2035
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of methylprednisolone in community acquired pneumonia (CAP), sponsored by Qingyuan Zhan. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
methylprednisolone
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT07152587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07152587.